title: Tolerance to class I-disparate renal allografts in miniature swine. Maintenance of tolerance despite induction of specific antidonor CTL responses.
abstract: Miniature swine that become tolerant to renal allografts across an MHC class I barrier following a short course of cyclosporine are unresponsive to donor class I antigens in cell-mediated lymphocytotoxicity. However, skin grafts bearing donor class I plus third-party class II antigens are promptly rejected, and the animals then develop marked cell-mediated lymphocytoxic reactivity to donor class I antigens in vitro, but do not reject the kidney transplants. We show here that CTL generation is directed toward the same donor class I antigens as are expressed by the kidney donor, and is not the result of recognition in vitro of the tolerated class I antigen plus peptides of minor antigens shared between the skin graft donor and the stimulator/target cells. We also show that detection by CTLs of peptides expressed by skin but not by kidney is also not a sufficient explantation of the results, since the survival of skin grafts from the kidney donor is also prolonged, even after precursor CTL can be detected in vitro. The data are most consistent with suppression in vivo in tolerant animals of the helper pathways necessary for activation of precursor CTLs. Differences in patterns of cytokine expression by graft infiltrating cells may provide a mechanism for local suppression of help in this model. Finally, we have examined antibody production after sensitizing by skin grafts in long-term tolerant animals and have found that anti-donor class I antibodies are not produced, even though the same animals produce both anti-class II and anti-third-party class I antibodies.
authors.affiliation: Transplantation Biology Research Center, Massachusetts General Hospital, Boston 02129.
authors.forename: P R
authors.initials: PR
authors.lastname: Gianello
authors.forename: J M
authors.initials: JM
authors.lastname: Fishbein
authors.forename: B R
authors.initials: BR
authors.lastname: Rosengard
authors.forename: T
authors.initials: T
authors.lastname: Lorf
authors.forename: D M
authors.initials: DM
authors.lastname: Vitiello
authors.forename: J S
authors.initials: JS
authors.lastname: Arn
authors.forename: D H
authors.initials: DH
authors.lastname: Sachs
mesh_terms: D000818:Animals; D000917:Antibody Formation / Q000276:immunology; D000918:Antibody Specificity; D005434:Flow Cytometry; D015395:Histocompatibility Antigens Class I / Q000276:immunology* / Q000494:pharmacology; D000949:Histocompatibility Antigens Class II / Q000276:immunology / Q000494:pharmacology; D007108:Immune Tolerance; D016030:Kidney Transplantation / Q000276:immunology*; D016038:Skin Transplantation / Q000276:immunology; D013552:Swine; D013556:Swine, Miniature / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D013997:Time Factors; D014019:Tissue Donors
chemical_list: D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II